5Zhu W, Mix E, Nennesmo I, et al. Anti-cytokine au- toantibodies in experimental autoimmune neuritis in Lewis rats[J]. Exp Neurol, 2004,190(2) :486-494.
6Wu Y, Wang H, Wang W, et al. A study of associated cell-mediated immune mechanisms in experimental auto- immune neuritis rats[ J]. J Neuroimmunol, 2007,185 ( 1- 2) :87-94.
7Hafer Macko C E, Sheikh K A, Li C Y, et al. Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy[ J ]. Ann Neurol, 1996,39 (5) :625-635.
8Radhakrishnan V V, Sumi M G, Reuben S, et al. Circu- lating tumour necrosis factor alpha & soluble TNF recep- tors in patients with Guillain-Barre syndrome[ J]. Indian J Med Res, 2003,117:216-220.
9Radhakrishnan V V, Sumi M G, Reuben S, et al. Serum tumour necrosis factor-alpha and soluble tumour necrosis factor receptors levels in patients with Guillain-Barre syn- drome [ J ]. Acta Neurol Scand, 2004,109 ( 1 ) :71-74.
10Di Marco R, Khademi M, Wallstrom E, et al. Ameliora- tion of experimental allergic neuritis by sodium fusidate (fusidin) : suppression of IFN-gamma and TNF-alpha and enhancement of IL-10 [J]. J Autoimmun, 1999,13(2) :187-195.
4Matsumoto Y, Kim G, Tanuma N. Characterization of T cell receptor associated with the development of P2 peptide-induced autoimmune neuritis [ J ]. Neuroimmunol, 2000,102 ( 1 ) : 67 - 72.
5Pritchard J. Novel therapeutic approaches to Guillain-Barre'syndrome [ J ]. Expert Opin Investig Drugs, 2000,9 (10) : 2307 -18.
6Monaco S, Turri E, Anusso G, et al. Treatment of inflammatory and paraproteinemic neuropathies [ J ]. Current Drugs Targets hnmune Endocr Metabol Disord, 2004,4 ( 2 ) : 141 - 8.
7Hughes R A, Hadden R D, Gregson N A, et al. Pathogenesis of Guillain-Barre'syndrome [ J ]. Neuroimmunol, 1999,100 ( 1 - 2 ) : 74 - 97.
8Radhakrishnan V V, Sumi M G, Reuben S, et al. Serum tumour necrosis factor-α and soluble tumour necrosis factor receptors levels in patients with Guillain-barre syndrome[ J ]. Acta Neurol Scand, 2004,109(2) :71 -4.
9Weishaupt A, Bruck W, Hartung T, et al. Schwann cell apoptosis in experimental autoimmune neuritis of the Lewis rat and the functional role of tumor necrosis factor-alpha[ J]. Neurosci Lett,2001, 306(1 -2) : 77 -80.
10Deretzi G, Zou L P, Pelidou S H, et al. Nasal administration of recombinant rat IL-4 ameliorates ongoing experimental autoimmune neuritis and inhibits demyelination [ J]. J Autoimmun, 1999,12 (2) :81 -9.
